Agreement between clinician-rated versus patient-reported outcomes in Huntington disease
- 23 April 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 265 (6) , 1443-1453
Abstract
Background Clinician-rated measures of functioning are often used as primary endpoints in clinical trials and other behavioral research in Huntington disease. As study costs for clinician-rated assessments are not always feasible, there is a question of whether patient self-report of commonly used clinician-rated measures may serve as acceptable alternatives in low risk behavioral trials. Aim The purpose of this paper was to determine the level of agreement between self-report and clinician-ratings of commonly used functional assessment measures in Huntington disease. Design 486 participants with premanifest or manifest Huntington disease were examined. Total Functional Capacity, Functional Assessment, and Independence Scale assessments from the Unified Huntington Disease Rating scale were completed by clinicians; a self-report version was also completed by individuals with Huntington disease. Cronbach’s α was used to examine internal consistency, one-way analysis of variance was used to examine group differences, and paired t tests, kappa agreement coefficients, and intra-class correlations were calculated to determine agreement between raters. Results Internal consistency for self-reported ratings of functional capacity and ability were good. There were significant differences between those with premanifest, early-, and late-stage disease; those with later-stage disease reported less ability and independence than the other clinical groups. Although self-report ratings were not a perfect match with associated clinician-rated measures, differences were small. Cutoffs for achieving specified levels of agreement are provided. Conclusions Depending on the acceptable margin of error in a study, self-reported administration of these functional assessments may be appropriate when clinician-related assessments are not feasible.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS077946, R01NS040068)
- National Center for Advancing Translational Sciences (UL1TR000433)
- National Institutes of Health (Center for Inherited Disease Research)
- CHDI Foundation
This publication has 54 references indexed in Scilit:
- Self‐awareness of executive dysfunction in Huntington's disease: Comparison with Parkinson's disease and cervical dystoniaPsychiatry and Clinical Neurosciences, 2013
- Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington diseaseJournal of Health Psychology, 2012
- Indexing disease progression at study entry with individuals at‐risk for Huntington diseaseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011
- Neurocognitive signs in prodromal Huntington disease.Neuropsychology, 2011
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisThe Lancet Neurology, 2011
- Huntington's disease: a clinical reviewOrphanet Journal of Rare Diseases, 2010
- Challenges assessing clinical endpoints in early Huntington diseaseMovement Disorders, 2010
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951